Xianzhang Bu

4.0k total citations · 2 hit papers
103 papers, 3.3k citations indexed

About

Xianzhang Bu is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Xianzhang Bu has authored 103 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 25 papers in Organic Chemistry and 19 papers in Pharmacology. Recurrent topics in Xianzhang Bu's work include Curcumin's Biomedical Applications (13 papers), Synthesis of Organic Compounds (10 papers) and Natural product bioactivities and synthesis (10 papers). Xianzhang Bu is often cited by papers focused on Curcumin's Biomedical Applications (13 papers), Synthesis of Organic Compounds (10 papers) and Natural product bioactivities and synthesis (10 papers). Xianzhang Bu collaborates with scholars based in China, Hong Kong and United States. Xianzhang Bu's co-authors include Jun Du, Shaohui Cai, Binhua P. Zhou, Xianfeng Wang, Hao Wang, Hongsheng Wang, Guohui Wan, Guanmin Jiang, Ge Zhang and Zhihong Guo and has published in prestigious journals such as Nature Communications, The EMBO Journal and ACS Nano.

In The Last Decade

Xianzhang Bu

101 papers receiving 3.2k citations

Hit Papers

TGF-β induces M2-like macrophage polarization via SNAIL-m... 2016 2026 2019 2022 2016 2020 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xianzhang Bu China 31 2.0k 608 601 560 441 103 3.3k
Chanakya Nath Kundu India 38 2.1k 1.1× 767 1.3× 990 1.6× 436 0.8× 363 0.8× 124 4.1k
Kodappully Sivaraman Siveen United States 38 2.7k 1.4× 386 0.6× 1.2k 2.1× 951 1.7× 628 1.4× 74 4.7k
Karuppaiyah Selvendiran United States 35 1.8k 0.9× 255 0.4× 687 1.1× 854 1.5× 268 0.6× 67 3.1k
Smitha Antony United States 40 2.9k 1.4× 1.2k 2.0× 1000 1.7× 567 1.0× 575 1.3× 74 4.3k
Sushil Kumar India 22 1.8k 0.9× 293 0.5× 793 1.3× 509 0.9× 334 0.8× 67 3.4k
Joong Sup Shim Macao 33 3.2k 1.6× 283 0.5× 994 1.7× 792 1.4× 328 0.7× 85 5.0k
Lorraine M. Deck United States 25 1.6k 0.8× 503 0.8× 292 0.5× 1000 1.8× 238 0.5× 44 3.2k
Anindita Chakrabarty India 31 1.6k 0.8× 310 0.5× 1.0k 1.7× 374 0.7× 315 0.7× 88 3.0k
Samuel K. Kulp United States 40 2.8k 1.4× 499 0.8× 1.0k 1.7× 738 1.3× 346 0.8× 120 4.4k
Ramzi M. Mohammad United States 41 2.9k 1.5× 280 0.5× 1.2k 2.1× 601 1.1× 374 0.8× 154 4.8k

Countries citing papers authored by Xianzhang Bu

Since Specialization
Citations

This map shows the geographic impact of Xianzhang Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianzhang Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianzhang Bu more than expected).

Fields of papers citing papers by Xianzhang Bu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianzhang Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianzhang Bu. The network helps show where Xianzhang Bu may publish in the future.

Co-authorship network of co-authors of Xianzhang Bu

This figure shows the co-authorship network connecting the top 25 collaborators of Xianzhang Bu. A scholar is included among the top collaborators of Xianzhang Bu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianzhang Bu. Xianzhang Bu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Weilin, Yuxuan Zhao, Wenjing Qin, et al.. (2025). Targeting USP1 Potentiates Radiation‐Induced Type I IFN‐Dependent Antitumor Immunity by Enhancing Oligo‐Ubiquitinated SAR1A‐Mediated STING Trafficking and Activation. Advanced Science. 12(15). e2412687–e2412687. 1 indexed citations
2.
Wang, Zeyi, Ziyi Liu, Jinyan Li, et al.. (2025). Targeting phagocytosis for amyloid-β clearance: implications of morphology remodeling and microglia activation probed by bifunctional chimaeras. Nature Communications. 16(1). 8128–8128. 1 indexed citations
3.
Li, Shuxin, Qiao-Li Wang, Guohui Wan, et al.. (2024). Formyl peptide enhances cancer immunotherapy by activating antitumoral neutrophils, and T cells. Biomedicine & Pharmacotherapy. 175. 116670–116670. 2 indexed citations
4.
Wang, Xiaoquan, Qinhong Luo, Daoyuan Chen, et al.. (2023). Development of cyclopeptide inhibitors of cGAS targeting protein-DNA interaction and phase separation. Nature Communications. 14(1). 6132–6132. 31 indexed citations
5.
Li, Lu, et al.. (2023). Disulfiram enhances cisplatin cytotoxicity by forming a novel platinum chelate Pt(DDTC)3+. Biochemical Pharmacology. 211. 115498–115498. 5 indexed citations
6.
Lin, Ziyou, Arabella Wan, Lei Sun, et al.. (2022). N6-methyladenosine demethylase FTO enhances chemo-resistance in colorectal cancer through SIVA1-mediated apoptosis. Molecular Therapy. 31(2). 517–534. 56 indexed citations
7.
Wu, Weijian, Huiying Xu, Jiaxin Wu, et al.. (2022). Blockade of USP14 potentiates type I interferon signaling and radiation-induced antitumor immunity via preventing IRF3 deubiquitination. Cellular Oncology. 45(6). 1347–1361. 4 indexed citations
8.
Lin, Ziyou, Yi Niu, Arabella Wan, et al.. (2020). RNA m 6 A methylation regulates sorafenib resistance in liver cancer through FOXO 3‐mediated autophagy. The EMBO Journal. 39(12). e103181–e103181. 359 indexed citations breakdown →
10.
Li, Manman, Xi Yu, Yongdong Zou, et al.. (2017). Synthesis and Evaluation of Diphenyl Conjugated Imidazole Derivatives as Potential Glutaminyl Cyclase Inhibitors for Treatment of Alzheimer’s Disease. Journal of Medicinal Chemistry. 60(15). 6664–6677. 46 indexed citations
11.
Yue, Xin, Yinglin Zuo, Jiaming Luo, et al.. (2017). Identification of 4-arylidene curcumin analogues as novel proteasome inhibitors for potential anticancer agents targeting 19S regulatory particle associated deubiquitinase. Biochemical Pharmacology. 137. 29–50. 15 indexed citations
13.
Jia, Yanyan, Shaorui Chen, Jiantao Ye, et al.. (2013). (E)-1-(4-ethoxyphenyl)-3-(4-nitrophenyl)-prop-2-en-1-one suppresses LPS-induced inflammatory response through inhibition of NF-κB signaling pathway. International Immunopharmacology. 15(4). 743–751. 10 indexed citations
14.
Liu, Hao, Binhua P. Zhou, Hongsheng Wang, et al.. (2012). T63, a new 4-arylidene curcumin analogue, induces cell cycle arrest and apoptosis through activation of the reactive oxygen species–FOXO3a pathway in lung cancer cells. Free Radical Biology and Medicine. 53(12). 2204–2217. 52 indexed citations
15.
Bu, Xianzhang. (2011). Effects of chemical synthesized curcumin preconditioning on the expression of AQP-4 and cerebral edema after focal cerebral ischemia/reperfusion damage in rats. Zhongguo yaolixue tongbao. 1 indexed citations
17.
Tian, Yuanxin, et al.. (2009). Natural tanshinone-like heterocyclic-fused ortho-quinones from regioselective Diels–Alder reaction: Synthesis and cytotoxicity evaluation. European Journal of Medicinal Chemistry. 44(10). 3915–3921. 13 indexed citations
18.
An, Lin‐Kun, et al.. (2007). The Reaction of Tanshinones with Diamines.. ChemInform. 38(3). 2 indexed citations
19.
An, Lin‐Kun, et al.. (2006). The reaction of tanshinones with diamines. Indian Journal of Chemistry Section B-organic Chemistry Including Medicinal Chemistry. 45(9). 2105–2111. 3 indexed citations
20.
Bu, Xianzhang, et al.. (1996). MOLECULAR RECOGNITION STUDY ON SUPRAMOLECULAR SYSTEM. (III): CHIRAL RECOGNITION OF AROMATIC AMINO ACIDS BY BINUCLEAR CU(II) COMPLEXES WITH CYCLODEXTRI NS. Civil War Book Review. 41(2). 117–122. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026